Literature DB >> 10425082

Pharmacotherapies for treatment of cocaine abuse: preclinical aspects.

F I Carroll1, L L Howell, M J Kuhar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10425082     DOI： 10.1021/jm9706729

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  52 in total

Review 1.  Current concepts in pharmacotherapy of substance abuse.

Authors:  P C Gottschalk; L K Jacobsen; T R Kosten
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801.

Authors:  G P Hess; H Ulrich; H G Breitinger; L Niu; A M Gameiro; C Grewer; S Srivastava; J E Ippolito; S M Lee; V Jayaraman; S E Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.

Authors:  Lokman Torun; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2012-02-08       Impact factor: 3.641

4.  Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates.

Authors:  Paul W Czoty; Jennifer L Martelle; F Ivy Carroll; Michael A Nader
Journal:  Pharmacol Biochem Behav       Date:  2010-05-24       Impact factor: 3.533

Review 5.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 6.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

7.  Influence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeys.

Authors:  B L Blaylock; R W Gould; A Banala; P Grundt; R R Luedtke; A H Newman; M A Nader
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

8.  Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.

Authors:  Nidhi Kaushal; Matthew J Robson; Harsha Vinnakota; Sanju Narayanan; Bonnie A Avery; Christopher R McCurdy; Rae R Matsumoto
Journal:  AAPS J       Date:  2011-04-15       Impact factor: 4.009

Review 9.  Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.

Authors:  F Ivy Carroll; James L Howard; Leonard L Howell; Barbara S Fox; Michael J Kuhar
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

10.  Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryloxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereoisomers for activity toward monoamine transporters.

Authors:  Prashant S Kharkar; Angela M Batman; Juan Zhen; Patrick M Beardsley; Maarten E A Reith; Aloke K Dutta
Journal:  ChemMedChem       Date:  2009-07       Impact factor: 3.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.